The COVID-19 vaccine-maker Pfizer/ BioNTech has begun the process of applying for full approval from US drug regulators.
It’s the first COVID-19 vaccine to be assessed for full- not just emergency- endorsement from the US Food and Drug Administration.
The news comes as Pfizer celebrates two studies showing its vaccine is highly effective against new variants.
Nina-Maria Potts reports:
IN: “ Pfizer’s mRNA…
OUT: SOC
DUR: 45 seconds